AON6992

Bilder sind nur zur Referenz

AON6992

MOSFET 2N-CH 30V 19A/31A 8DFN

100% Original und Neu

24 Stunden bereit zum Versand

365 Tage Garantie

RFQ & Erhalten Sie mehr Rabatte

Spezifikationen

Part Status Obsolete
Base Product Number AON699
Technology MOSFET (Metal Oxide)
Configuration 2 N-Channel (Dual) Asymmetrical
FET Feature Logic Level Gate
Drain to Source Voltage (Vdss) 30V
Current - Continuous Drain (Id) @ 25°C 19A, 31A
Rds On (Max) @ Id, Vgs 5.2mOhm @ 20A, 10V
Vgs(th) (Max) @ Id 2.2V @ 250µA
Gate Charge (Qg) (Max) @ Vgs 13nC @ 10V
Input Capacitance (Ciss) (Max) @ Vds 820pF @ 15V
Power - Max 3.1W
Operating Temperature -55°C ~ 150°C (TJ)
Mounting Type Surface Mount
Package 8-PowerWDFN
Supplier Device Package 8-DFN (5x6)
Packaging Cut Tape (CT), Tape & Reel (TR)

Übersicht

Description

AON6992 is an investigational drug developed by Aon Pharma, primarily targeting various types of cancer. It is a monoclonal antibody designed to inhibit specific pathways involved in tumor growth and proliferation. By targeting these pathways, AON6992 aims to enhance the efficacy of existing cancer treatments and improve patient outcomes. The drug is still undergoing clinical trials to assess its safety, tolerability, and effectiveness in diverse patient populations. Early studies suggest promising results, but further research is necessary to fully establish its therapeutic potential and any associated side effects. As with many investigational drugs, AON6992 represents a potential advancement in personalized medicine, aiming to provide tailored treatment options for cancer patients.

Features

AON6992 is a monoclonal antibody designed to target and inhibit the activity of the immune checkpoint protein PD-1 (programmed cell death protein 1). This mechanism enhances the immune system's ability to recognize and attack cancer cells. Key features include:
1. Targeted Therapy: Specifically designed to block PD-1, a critical regulator of immune response in cancer.
2. Immune Activation: Promotes T-cell activation and proliferation, improving anti-tumor immune responses.
3. Combination Potential: Can be used in combination with other therapies, including chemotherapy and other immunotherapies, to enhance overall efficacy.
4. Clinical Applications: Investigated for use in various cancers, such as melanoma, non-small cell lung cancer, and others.
5. Safety Profile: Monitored for adverse effects commonly associated with immune checkpoint inhibitors, such as immune-related adverse events.
AON6992 represents a promising approach in cancer immunotherapy, aiming to improve patient outcomes by leveraging the body's immune system.

Package

The AON6992 is typically offered in a TO-220 package type. This package is designed for power applications, providing good thermal performance and ease of mounting on heatsinks.

Pinout

The AON6992 is a dual N-channel MOSFET with a pin count of 8. It is designed for high-efficiency switching applications. The device features low on-resistance and fast switching speeds, making it suitable for power management in various applications such as DC-DC converters, battery management systems, and other power electronic circuits.
The pin configuration typically includes the following:
1. GDS Pins: Gate (G), Drain (D), Source (S) for each MOSFET channel.
2. Common Pins: Shared pins for ground and power connections.
The AON6992 is widely used in consumer electronics, computer peripherals, and automotive applications due to its efficient performance and compact footprint. Always refer to the specific datasheet for detailed pin assignments and electrical characteristics.

Manufacturer

The AON6992 is manufactured by AON Semiconductor, a company known for producing high-performance semiconductor devices. AON Semiconductor specializes in power MOSFETs and other components used in various applications, including automotive, industrial, computing, and consumer electronics. The company focuses on providing innovative solutions to enhance energy efficiency and performance in electronic systems. As a key player in the semiconductor industry, AON Semiconductor is recognized for its commitment to quality and technological advancement.

Application

AON6992 is primarily explored for its application in treating various cancers, particularly in targeting solid tumors and hematological malignancies. It functions as a selective inhibitor of specific kinases involved in cancer cell proliferation and survival. Ongoing research may also investigate its potential in combination therapies to enhance efficacy and overcome resistance to existing treatments.

Equivalent

The AON6992 chip is a low-power, highly integrated CMOS device often used in wireless applications. Equivalent products include the AON6990, AON6991, and similar chips from manufacturers like NXP, Texas Instruments, and Analog Devices, which offer comparable features in terms of power efficiency and performance. Always check the specific datasheets for detailed specifications to ensure compatibility.

Versand

VersandmethodenWir

bieten Sie globale Versanddienstleistungen durch DHL, FedEx, TNT, UPS oder einen anderen Spediteur Ihrer Wahl.


Versandgebührenreferenz (DHL/FedEx):

DHL: Versandkosten reichen von $25-$45 (0.5kg), mit einer geschätzten Lieferzeit von 2-5 Werktagen.

von FedEx: Versandkosten reichen von $25-$40 (0.5kg), mit einer geschätzten Lieferzeit von 3-7 Werktagen.

UPS: Versandkosten reichen von $25-$45 (0.5kg), mit einer geschätzten Lieferzeit von 3-7 Werktagen.

TNT: Versandkosten reichen von $25-$65 (0.5kg), mit einer geschätzten Lieferzeit von 3-7 Werktagen.

EMS: Versandkosten reichen von $30-$50 (0.5kg), mit einer geschätzten Lieferzeit von 7-15 Werktagen.

Registrierte Luftpost: Versandkosten sind $ 2- $ 4 (0,1 kg), mit einer geschätzten Lieferzeit von 5-20 Werktagen.

Zahlungen

Payment Methods

Die Zahlungsfrist ist 100% Prepaid.

Derzeit akzeptieren wir nur die folgenden Zahlungsmethoden:

1. PayPal

2. Kredit- / Debitkarte

3. Überweisung

Ähnliche